End­points 11 win­ner Car­du­ri­on Phar­ma­ceu­ti­cals: A shot at one of heart dis­ease’s 'un­drug­gable' tar­gets

  • CEO Pe­ter Lawrence
  • To­tal raised More than $500 mil­lion
  • Head­quar­ters Burling­ton, MA

‘Un­drug­gable’ tar­gets aren’t just in on­col­o­gy. Car­du­ri­on Phar­ma­ceu­ti­cals …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA